Patent US1832436A successfully refreshed from Google Patents.
US4489710A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Composition and method for transplantation therapy
Assignee: Xoma Royalty Corp
•
Filing: 1982-10-18
•
Granted: 1984-12-25
•
Expires: 2002-10-18
Abstract
Abstract An improved transplantion therapy and method is provided which comprises specifically killing cells known to be problematic in the transplantion process. Novel compositions of the present invention are conjugates prepared by generating antibodies specific to surface receptors of the unwanted cells, preparing Fab or F(ab') 2 fragments from the antibodies, and coupling the fragments to A chains of lectins or other cytotoxic agents to render the conjugates thus formed strongly cytotoxic to the cells to which the antibody was directed. The conjugates are used in vitro to eliminate unwanted cells prior to bone marrow transplantation.
Inventors
- 👤 Lynn E. Spitler
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 03:36
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/18; C07K16/28; C07K16/2803; C07K16/2809; Y; Y10; Y10S; Y10S424/00; Y10S424/809; Y10S530/00; Y10S530/866
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
71 words
A method of transplanting bone marrow from a donor to host comprising the steps of: (a) removing a sample of bone marrow from the donor; (b) incubating said sample with a composition useful in transplantation therapy which is a conjugate of a monospecific anti-mature T-cell antibody and a cytotoxin for mature T-cell to kill any mature T-cell present in said sample; and (c) introducing said bone marrow sample into the host.
Claim 2
Independent Claim
71 words
A method of transplanting bone marrow from a donor to host comprising the steps of: (a) removing a sample of bone marrow from the donor; (b) incubating said sample with a composition useful in transplantation therapy which is a conjugate of a monospecific anti-mature T-cell antibody and a cytotoxin for mature T-cell to kill any mature T-cell present in said sample; and (c) introducing said bone marrow sample into the host.
Claim 3
Dependent Claim
86 words
In the method of transplanting bone marrow from a donor to an immunologically incompetent host wherein a bone marrow sample comprising mature and immature T-cells is removed from the donor and injected into said host, the improvement comprising killing the mature T-cells of said sample prior to injecting said sample into said host by incubating said sample with an anti-mature T-cell-toxin conjugate prepared by the steps of: (a) preparing a monospecific antibody to mature T-cells; and (b) conjugating said antibody to a cytotoxin for mature T-cells.
Claim 4
Dependent Claim
86 words
In the method of transplanting bone marrow from a donor to an immunologically incompetent host wherein a bone marrow sample comprising mature and immature T-cells is removed from the donor and injected into said host, the improvement comprising killing the mature T-cells of said sample prior to injecting said sample into said host by incubating said sample with an anti-mature T-cell-toxin conjugate prepared by the steps of: (a) preparing a monospecific antibody to mature T-cells; and (b) conjugating said antibody to a cytotoxin for mature T-cells.
Claim 5
Dependent Claim
33 words
A method according to claim 2 wherein said monospecific antibody to mature T-cells is a monoclonal antibody and is prepared by fusing a cell which produces anti-mature T-cell antibody with a myeloma cell.
Claim 6
Dependent Claim
25 words
A method according to claim 2 wherein said cytotoxin is the A chain of a toxin selected from the group consisting of lectins and diphtheria.
Claim 7
Dependent Claim
31 words
A method in accordance with claim 2 wherein the antibody of said conjugate is an antibody fragment selected from the group consisting of Fab, Fab', Fab 2 and F(ab') 2 fragments.
Claim 8
Dependent Claim
20 words
A method according to claim 5 wherein said Fab fragment is obtained by enzymatic cleavage of said anti-mature T-cell antibody.
References Cited (Backward Citations)
GB2038836A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-12-25 | 1988-06-25 | 1988-12-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-12-25 | 1992-06-25 | 1992-12-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-12-25 | 1996-06-25 | 1996-12-25 | $7700.00 | Window Closed / Lapsed |